AstraZeneca vaccine: loved on the island, outlawed in the EU

The corona vaccination has long since become a political issue in Europe.

In view of the vaccination successes in their own country, where 39 percent of the population have now received the first dose of a vaccine, many Britons look only puzzled at the European continent.

And now the vaccine developed by AstraZeneca in Oxford is falling into disrepute in many EU countries.

The British think they know why.